Previously it was shown that a brief yoga-based lifestyle intervention was efficacious in reducing oxidative stress and risk of chronic diseases even in a short duration. The objective of this study was to assess the efficacy of this intervention in reducing stress and inflammation in patients with chronic inflammatory diseases.
Design:
This study reports preliminary results from a nonrandomized prospective ongoing study with pre–post design.
Setting/location:
The study was conducted at the Integral Health Clinic, an outpatient facility conducting these yoga-based lifestyle intervention programs for prevention and management of chronic diseases.
Subjects:
Patients with chronic inflammatory diseases and overweight/obese subjects were included while physically challenged, and those on other interventions were excluded from the study.
Intervention:
A pretested intervention program included asanas (postures), pranayama (breathing exercises), stress management, group discussions, lectures, and individualized advice.
Outcome measures:
There was a reduction in stress (plasma cortisol and β-endorphin) and inflammation (interleukin [IL]-6 and tumor necrosis factor [TNF]-α) at day 0 versus day 10.
Results:
Eighty-six (86) patients (44 female, 42 male, 40.07±13.91 years) attended this program. Overall, the mean level of cortisol decreased from baseline to day 10 (149.95±46.07, 129.07±33.30 ng/mL; p=0.001) while β-endorphins increased from baseline to day 10 (3.53±0.88, 4.06±0.79 ng/mL; p=0.024). Also, there was reduction from baseline to day 10 in mean levels of IL-6 (2.16±0.42, 1.94±0.10 pg/mL, p=0.036) and TNF-α (2.85±0.59, 1.95±0.32 pg/mL, p=0.002).
Conclusions:
This brief yoga-based lifestyle intervention reduced the markers of stress and inflammation as early as 10 days in patients with chronic diseases; however, complete results of this study will confirm whether this program has utility as complementary and alternative therapy.
Get full access to this article
View all access options for this article.
References
1.
MarsollierN, FerréP, FoufelleF. Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR. J Hepatol, 2011Feb4e-pub ahead of print.
2.
GadeW, SchmitJ, CollinsM, GadeJ. Beyond obesity: The diagnosis and pathophysiology of metabolic syndrome. Clin Lab Sci, 2010; 23:51–61quiz 62–65.
3.
NowotnyB, CavkaM, HerderCet al.Effects of acute psychological stress on glucose metabolism and subclinical inflammation in patients with post-traumatic stress disorder. Horm Metab Res, 2010; 42:746–753.
4.
RaisonCL, CapuronL, MillerAH. Cytokines sing the blues: Inflammation and the pathogenesis of major depression. Trend Immun, 2006; 27:24–31.
5.
RaisonCL, MillerAH. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry, 2003; 160:1554–1565.
6.
RasmussonAM, SchnurrPP, ZukowskaZet al.Adaptation to extreme stress: Post-traumatic stress disorder, neuropeptide Y and metabolic syndrome. Exp Biol Med (Maywood), 2010; 235:1150–1162.
7.
RoelfsemaF, KokP, PereiraAM, PijlH. Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome. J Clin Endocrinol Metab, 2010; 95:3318–3324.
8.
ReynoldsRM, LabadJ, StrachanMWet al.Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: The Edinburgh type 2 diabetes study. J Clin Endocrinol Metab, 2010; 95:1602–1608.
VogelzangsN, BeekmanAT, DikMGet al.Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry, 2009; 17:716–721.
11.
KudielkaBM, WüstS. Human models in acute and chronic stress: Assessing determinants of individual hypothalamus-pituitary-adrenal axis activity and reactivity. Stress, 2010; 13:1–14.
12.
KimJH, BachmannRA, ChenJ. Interleukin-6 and insulin resistance. Vitam Horm, 2009; 80:613–633.
DuvnjakL, DuvnjakM. The metabolic syndrome: An ongoing story. J Physiol Pharmacol, 2009; 60,suppl 7:19–24.
15.
GrivennikovSI, KarinM. Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis, 2011; 70,suppl 1:i104–i108.
16.
FidanE, Onder ErsozH, YilmazMet al.The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol, 2011Mar23e-pub ahead of print.
17.
BijlaniRL. Scientific medicine shows signs of a paradigm shift. New Approaches Med Health (NAMAH), 2003; 11:28–40.
18.
Kiecolt-GlaserJK, McGuireL, RoblesTF, GlaserR. Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annu Rev Psychol, 2002; 53:83–107.
19.
TaylorDN. Effects of a behavioral stress-management program on anxiety, mood, self-esteem, and T-cell count in HIV positive men. Psychol Rep, 1995; 76:451–457.
20.
CarlsonLE, SpecaM, PatelKD, FarisP. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun, 2007; 21:1038–1049.
21.
CarlsonLE, SpecaM, PatelKD, GoodeyE. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med, 2003; 65:571–581.
22.
DamodaranA, MalathiA, PatilNet al.Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Physicians India, 2002; 50:633–640.
23.
ManchandaSC, NarangR, ReddyKSet al.Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Physicians India, 2000; 48:687–694.
24.
DavidsonRJ, Kabat-ZinnJ, SchumacherJet al.Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med, 2003; 65:564–570.
25.
FuD, FuH, McGowanPet al.Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: Randomized controlled trial. Bull World Health Organization, 2003; 81:174–182.
26.
GriffithsC, MotlibJ, AzadAet al.Randomised controlled trial of a lay-led self-management programme for Bangladeshi patients with chronic disease. Br J Gen Pract, 2005; 55:831–837.
27.
SwerissenH, BelfrageJ, WeeksAet al.A randomised control trial of a self-management program for people with a chronic illness from Vietnamese, Chinese, Italian and Greek backgrounds. Patient Educ Counsel, 2006; 64:360–368.
28.
MatousekRH, DobkinPL, PruessnerJ. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract, 2010; 16:13–19.
29.
YadavRK, RayRB, VempatiR, BijlaniRL. Effect of a comprehensive yoga-based lifestyle modification program on lipid peroxidation. Indian J Physiol Pharmacol, 2005; 49:358–362.
30.
BijlaniRL, VempatiRP, YadavRKet al.A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Altern Complement Med, 2005; 11:267–274.
31.
MohanA, SharmaR, BijlaniRL. Effect of meditation on stress-induced changes in cognitive functions. J Altern Complement Med, 2011; 17:207–212.
32.
Martín-AsueroA, García-BandaG. The Mindfulness-based Stress Reduction program (MBSR) reduces stress-related psychological distress in healthcare professionals. Span J Psychol, 2010; 13:897–905.
33.
DarnallBD, AickinM, ZwickeyH. Pilot study of inflammatory responses following a negative imaginal focus in persons with chronic pain: Analysis by sex/gender. Gend Med, 2010; 7:247–260.
34.
NepomnaschyPA, AltmanRM, WattersonRet al.Is cortisol excretion independent of menstrual cycle day? A longitudinal evaluation of first morning urinary specimens. PLoS One, 2011; 6:e18242.
35.
FerrerJ, Mtnez-GuisasolaJ, DíazFet al.Plasma levels of beta-endorphin during the menstrual cycle. Gynecol Endocrinol, 1997; 11:75–82.
36.
PaceTW, NegiLT, AdameDDet al.Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology, 2009; 34:87–98.
37.
HarteJL, EifertGH, SmithR. The effect of running and meditation on beta-endorphin, corticotrophin-releasing hormone and cortisol in plasma, and on mood. Biol Psychol, 1995; 40:251–265.
38.
FelšöciM, SchronerZ, PetrovičováJ, LazúrováI. Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis. Wien Klin Wochenschr, 2011; 123:28–33.
39.
OlffM. Stress, depression and immunity: The role of defense and coping styles. Psychiatry Res, 1999; 85:7–15.
40.
OuHY, ChengJT, YuEH, WuTJ. Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects. Horm Metab Res, 2006; 38:106–111.
41.
SuCF, ChangYY, PaiHHet al.Mediation of beta-endorphin in exercise-induced improvement in insulin resistance in obese Zucker rats. Diabetes Metab Res Rev, 2005; 21:175–182.
42.
CozzolinoD, SassoFC, CataldoDet al.Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: Role of opioid receptor agonism. J Clin Endocrinol Metab, 2005; 90:5167–5174.
43.
PoantăL, CrăciunA, DumitraşcuDL. Professional stress and inflammatory markers in physicians. Rom J Intern Med, 2010; 48:57–63.
44.
O'ConnorDB, HendrickxH, DaddTet al.Cortisol awakening rise in middle-aged women in relation to psychological stress. Psychoneuroendocrinology, 2009; 34:1486–1494.
45.
DevarajS, DasuMR, JialalI. Diabetes is a proinflammatory state: A translational perspective. Expert Rev Endocrinol Metab, 2010; 5:19–28.
46.
MazorR, ItzhakiO, SelaSet al.Tumor necrosis factor-alpha: A possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Hypertension, 2010; 55:353–362.
47.
DinhW, FüthR, NicklWet al.Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol, 2009; 8:58.
48.
WuW, WangM, SunZet al.The predictive value of TNF-alpha and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes. Acta Diabetol, 2010May21e-pub ahead of print.
49.
YeoES, HwangJY, ParkJEet al.Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes. Yonsei Med J, 2010; 51:519–525.
50.
BelottoMF, MagdalonJ, RodriguesHGet al.Moderate exercise improves leucocyte function and decreases inflammation in diabetes. Clin Exp Immunol, 2010; 162:237–243.
51.
EdwardsKM, ZieglerMG, MillsPJ. The potential anti-inflammatory benefits of improving physical fitness in hypertension. J Hypertens, 2007; 25:1533–1542.
52.
KamaeiT, ToriumiY, KirmuraHet al.Decrease in serum cortisol during yoga exercise is correlated with alpha wave activation. Percept Mot Skills, 2000; 90:1027–1032.
53.
Buske-KirschbaumA, EbrechtM, HellhammerDH. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun, 2010; 24:1347–1353.
54.
PhamMN, HawaMI, PflegerCet al.Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia, 2011Feb24e-pub ahead of print.
55.
DobkinPL, ZhaoQ. Increased mindfulness: The active component of the mindfulness-based stress reduction program?Complement Ther Clin Pract, 2011; 17:22–27.
56.
PopkoK, GorskaE, Stelmaszczyk-EmmelAet al.Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res, 2010; 15,suppl 2:120–122.
57.
BauneBT, RothermundtM, LadwigKHet al.Systemic inflammation (interleukin 6) predicts all-cause mortality in men: Results from a 9-year follow-up of the MEMO Study. Age (Dordr), 2011; 33:209–217.
